| Horizon Minerals Limited (HRZ) ORDINARY FULLY PAID |
Materials |
$284 |
Continued High-Grade Success from Burbanks Phase 1 Drilling
|
28 Jan 2026 9:29AM |
$1.350 |
$1.380 |
risen by
2.22%
|
|
HRZ - Price-sensitive ASX Announcement
Full Release
Key Points
- 75% of 15,000m Phase 1 diamond drill program completed.
- Significant high-grade gold assays reported.
- 2.00m @ 235.7g/t Au from 248.31m and 1.16m @ 396.62g/t Au.
- Two metallurgical holes completed for mine feed planning.
- Updated Mineral Resource Estimate expected by June 2026.
- Phase 2 extensional drilling planned for early 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Franklin Australian Absolute Return Bond Fund (Managed Fund) (FRAR) |
Financials |
$716 |
Distribution Details 31 January 2026
|
28 Jan 2026 9:28AM |
$1.045 |
$1.050 |
risen by
0.48%
|
|
| Santa Fe Minerals Ltd (SFM) ORDINARY FULLY PAID |
Materials |
$45 |
Application for quotation of securities - SFM
|
28 Jan 2026 9:27AM |
$0.310 |
$0.315 |
risen by
1.61%
|
|
| NICO Resources Limited (NC1) ORDINARY FULLY PAID |
Materials |
$36 |
Notice Under Section 708A
|
28 Jan 2026 9:27AM |
$0.305 |
$0.260 |
fallen by
14.75%
|
|
| ASX Limited (ASX) ORDINARY FULLY PAID |
Financials |
$11,129 |
Unaudited 1H26 Results and Updated FY26 Expense Guidance
|
28 Jan 2026 9:27AM |
$53.640 |
$57.280 |
risen by
6.79%
|
|
ASX - Price-sensitive ASX Announcement
Full Release
Key Points
- Operating revenue for 1H26 was $602.8 million, up 11.2%.
- Total expenses excluding ASIC Inquiry costs were $247.0 million, up 12.1%.
- Total expenses including ASIC Inquiry costs were $264.3 million, up 20.0%.
- Statutory net profit after tax increased by 8.3% to $263.6 million.
- ASX updated FY26 expense growth guidance to 13%-15% excluding ASIC costs and 20%-23% including them.
- The ASIC Inquiry Panel's report emphasized a need for transformation in ASX operations.
- Investments continue in technology modernization and the Accelerate program.
- CEO emphasized importance of ASX's role as an operator of critical market infrastructure.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Excite Technology Services Limited (EXT) ORDINARY FULLY PAID |
Information Technology |
$19 |
Application for quotation of securities - EXT
|
28 Jan 2026 9:26AM |
$0.008 |
$0.009 |
risen by
12.50%
|
|
| Vulcan Energy Resources Limited (VUL) ORDINARY FULLY PAID |
Materials |
$1,921 |
Change in substantial holding
|
28 Jan 2026 9:26AM |
$4.450 |
$4.020 |
fallen by
9.66%
|
|
| Iron Road Limited (IRD) ORDINARY FULLY PAID |
Materials |
$22 |
Quarterly Activities and Cashflow Report 31 December 2025
|
28 Jan 2026 9:26AM |
$0.028 |
$0.027 |
fallen by
3.57%
|
|
IRD - Price-sensitive ASX Announcement
Full Release
Key Points
- Net cash used in operating activities amounted to AUD 361,000 for the current quarter.
- Cash flows from investing activities resulted in a net outflow of AUD 264,000, mainly for exploration and evaluation.
- Financing activities included a AUD 259,000 repayment to an investor related to an earlier share prepayment.
- The company held cash reserves of AUD 1.8 million at the end of the quarter with no debt.
- Iron Road continued exploration activities at the Mulgathing Project, focusing on Heavy Mineral Sands and a nickel-copper-gold target.
- Revera Energy declined to exercise a land purchase option at Cape Hardy for hydrogen development.
- Global crude steel production fell by 2% in 2025, impacting iron ore demand.
- The company reported stable iron ore prices despite global market conditions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Arcadia Minerals Limited (AM7) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$4 |
Trading Halt
|
28 Jan 2026 9:26AM |
$0.036 |
$0.036 |
fallen by
0%
|
|
AM7 - Price-sensitive ASX Announcement
Full Release
Key Points
- Arcadia Minerals Limited requested a trading halt on 28 January 2026.
- The halt is related to a proposed capital raising and earn-in on the Swanson Tantalum mine.
- The trading halt will continue until the earlier of 30 January 2026 or the announcement release.
- The company is in compliance with ASX Listing Rule 17.1.
- No additional information or reasons were indicated that might prevent the trading halt.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Iluka Resources Limited (ILU) ORDINARY FULLY PAID |
Materials |
$2,303 |
Change in substantial holding
|
28 Jan 2026 9:25AM |
$6.640 |
$5.360 |
fallen by
19.28%
|
|
| Cannindah Resources Limited (CAE) ORDINARY FULLY PAID |
Materials |
$58 |
Potential Significant Copper Gold Porphyry Intersected
|
28 Jan 2026 9:25AM |
$0.045 |
$0.056 |
risen by
24.44%
|
|
CAE - Price-sensitive ASX Announcement
Full Release
Key Points
- Significant copper and gold-rich system confirmed at Mt Cannindah.
- Southern Porphyry Target has a footprint of over 2000m by 800m.
- High-grade intersections found, notably 28m at 1.15% CuEq.
- Potential for significant porphyry-related Cu Au Ag Mo resources.
- Further deep drilling planned to explore the system's extent.
- Project deemed one of the best copper-gold projects in Australia.
- Exploration strategy and technical conclusions validated by results.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Patronus Resources Limited (PTN) ORDINARY FULLY PAID |
Materials |
$109 |
CGR: Strategic Leonora Landholding Acquired, Desdemona Proj
|
28 Jan 2026 9:25AM |
$0.077 |
$0.074 |
fallen by
3.90%
|
|
PTN - Price-sensitive ASX Announcement
Full Release
Key Points
- Binding agreement to acquire 100% of gold tenure from Patronus Resources in Leonora.
- Acquisition expands CGN's landholding to 386 km² in the Leonora Gold Province.
- New land situated along strike from Tier-1 gold mines such as Gwalia and King of the Hills.
- Combined landholding positions CGN among largest in Leonora District.
- Acquisition structured to conserve cash for exploration.
- Patronus Resources to join CGN's share register.
- Potential for new gold discoveries through systematic exploration.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| CGN Resources Limited (CGR) ORDINARY FULLY PAID |
Materials |
$10 |
Strategic Leonora Landholding Acquired, Desdemona Project
|
28 Jan 2026 9:25AM |
$0.095 |
$0.095 |
fallen by
0%
|
|
CGR - Price-sensitive ASX Announcement
Full Release
Key Points
- CGN Resources Limited has executed a binding agreement to acquire 100% of a strategically located gold tenure package from Patronus Resources in the Leonora district, Western Australia.
- The acquisition includes three mining licenses, eight exploration licenses, and nine prospecting licenses, totaling 142 km2.
- The newly acquired landholding is adjacent to multiple Tier-1 gold mines like Gwalia, King of the Hills, and Ulysses.
- CGN's consolidated holdings now cover 386 km2, positioning it as a dominant player in the Leonora Gold region.
- The acquisition includes a straightforward deal structure, involving CGN shares and milestone-based cash payments.
- The newly acquired areas have significant unexplored potential due to past focus on shallow oxide gold targets.
- CGN aims to integrate historical data with existing datasets to develop a robust pipeline of exploration targets.
- The acquisition represents a significant step in CGN's Leonora growth strategy, enhancing its exploration opportunities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Imricor Medical Systems Inc (IMR) CDI 1:1 US PERSON PROHIBITED EXCLUDING QIB |
Health Care |
$635 |
Imricor Q4 CY25 Quarterly Activities Report and Appendix 4C
|
28 Jan 2026 9:24AM |
$1.900 |
$1.980 |
risen by
4.21%
|
|
IMR - Price-sensitive ASX Announcement
Full Release
Key Points
- Imricor Medical Systems, Inc. released its Appendix 4C Quarterly Cash Flow Report for the period ended 31 December 2025.
- Imricor reported net cash outflows from operating activities of US$5.2 million for the quarter.
- Receipts from customers during the period were US$26 thousand.
- Imricor held a cash balance of US$19.5 million at the end of the quarter.
- Imricor is pioneering real-time MRI-guided cardiac ablations, providing safer and more effective treatment compared to x-ray.
- Multiple world-first procedures were achieved in the quarter, advancing the company's clinical trial footprint.
- Total cash and short-term investments amounted to US$40.8 million as of the end of the quarter.
- Imricor's market for cardiac ablations is estimated to be over US$12 billion worldwide.
- The company is expanding its presence in the Middle East, Australia, and New Zealand.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Rhythm Biosciences Limited (RHY) ORDINARY FULLY PAID |
Health Care |
$47 |
Rhythm Biosciences secures commercial alliance with CancerIQ
|
28 Jan 2026 9:23AM |
$0.140 |
$0.145 |
risen by
3.57%
|
|
| Emyria Limited (EMD) ORDINARY FULLY PAID |
Health Care |
$47 |
December 2025 Quarterly Activities Report and Appendix 4C
|
28 Jan 2026 9:22AM |
$0.058 |
$0.058 |
fallen by
0%
|
|
EMD - Price-sensitive ASX Announcement
Full Release
Key Points
- Emyria Limited national Empax clinic network expansion.
- Raised $8.0 million for national clinic rollout.
- Clinics established in Western Australia, Queensland, and Victoria.
- Revenue for the quarter was ~$892,000.
- Dual reimbursement pathways with private insurers and government payers.
- Increased capacity at Perth clinic and commenced treatments in Brisbane.
- Focus on activating more clinics and improving patient outcomes in CY2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| SenSen Networks Limited (SNS) ORDINARY FULLY PAID |
Information Technology |
$45 |
Quarterly Activities Report and Appendix 4C - Dec-2025 Qtr
|
28 Jan 2026 9:22AM |
$0.063 |
$0.054 |
fallen by
14.29%
|
|
SNS - Price-sensitive ASX Announcement
Full Release
Key Points
- H1 cash receipts increased by 20% year-on-year to $7.5 million.
- Secured five new city contracts in North America.
- SenPIC solution trials to start with Victorian councils in Q3 FY26.
- 115% increase in usage revenue driven by new technology.
- Cash balance of $0.4 million with undrawn debt facilities of $1.6 million.
- Expecting a $2.05 million R&D tax offset refund.
- Higher costs due to inventory investments and staff payment timing differences.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Alliance Nickel Limited (AXN) ORDINARY FULLY PAID |
Materials |
$37 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
28 Jan 2026 9:20AM |
$0.050 |
$0.048 |
fallen by
4%
|
|
AXN - Price-sensitive ASX Announcement
Full Release
Key Points
- 31% increase in Ore Reserves to 84.7 Mt.
- NiWest Project positioned in first cost quartile for AISC.
- Termination of strategic partnership with Stellantis N.V.
- Cash flow statement shows 2.39 quarters of funding available.
- Compliance with ASX Listing Rules and Australian Accounting Standards.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| X2M Connect Limited (X2M) ORDINARY FULLY PAID |
Information Technology |
$10 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
28 Jan 2026 9:20AM |
$0.009 |
$0.010 |
risen by
11.11%
|
|
X2M - Price-sensitive ASX Announcement
Full Release
Key Points
- X2M Connect Limited reported a 65% increase in revenues to $2.8 million for 2Q FY26.
- Gross profit for the quarter rose by 63% to $1.2 million compared to the previous year.
- Net cash generated from operating activities was $1.7 million.
- The company’s enterprise and government client base increased to 88 customers, a 10% rise.
- X2M is expanding its operations in South Korea and Japan, specifically in water digitisation.
- The company is focusing on enhancing its IoT solutions and expanding its market presence.
- Total cash at the end of December 2025 was $1.9 million, with net debt standing at $0.2 million.
- X2M expects continued revenue growth and a substantial improvement in adjusted EBITDA losses for FY26.
- X2M secured new contracts in South Korea and entered the Japanese water market.
- The company delivered 30,000 HelpMe public safety devices to the city of Seoul.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Radiopharm Theranostics Limited (RAD) ORDINARY FULLY PAID |
Health Care |
- |
Quarterly Activities/Appendix 4C Cash Flow Report
|
28 Jan 2026 9:19AM |
$0.023 |
$0.021 |
fallen by
8.70%
|
|
RAD - Price-sensitive ASX Announcement
Full Release
Key Points
- Radiopharm Theranostics announced financial results for H1 FY 2026 ending 31 December 2025.
- RAD 101 Phase 2b trial showed 92% imaging concordance in brain metastases.
- Cash reserves of $34.52 million extend runway into 2027.
- Significant equity financing raised $35.26 million.
- RAD 202 and RAD 204 trials progressing with new data expected in mid-2026.
- RAD 402 approved for Phase 1 trial in prostate cancer.
- Continued focus on advancing oncology radiopharmaceuticals.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Iron Road Limited (IRD) ORDINARY FULLY PAID |
Materials |
$22 |
Update - Notification of buy-back - IRD
|
28 Jan 2026 9:18AM |
$0.028 |
$0.027 |
fallen by
3.57%
|
|
| AUB Group Limited (AUB) ORDINARY FULLY PAID |
Financials |
$3,933 |
AUB Group successfully completes AUD 400mn placement
|
28 Jan 2026 9:17AM |
$31.910 |
$30.210 |
fallen by
5.33%
|
|
AUB - Price-sensitive ASX Announcement
Full Release
Key Points
- AUB Group completed an AUD 400mn placement.
- Approximately 13.6mn shares were issued at AUD 29.40.
- The placement saw strong demand from existing and new investors.
- Funds will be used for the acquisition of Prestige and other opportunities.
- AUB plans a non-underwritten AUD 40mn Share Purchase Plan.
- The SPP offer period is from 4 February to 26 February 2026.
- Shares in the SPP will be issued at a discount based on the VWAP.
- AUB aims to accelerate its UK Retail strategy with this funding.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Antilles Gold Limited (AAU) ORDINARY FULLY PAID |
Materials |
$50 |
Finance Manager Appointed for Cuban Mining Projects
|
28 Jan 2026 9:17AM |
$0.017 |
$0.016 |
fallen by
5.88%
|
|
| archTIS Limited (AR9) ORDINARY FULLY PAID |
Information Technology |
$47 |
AR9 Completes US Department of Defense Development Project
|
28 Jan 2026 9:16AM |
$0.110 |
$0.098 |
fallen by
10.91%
|
|
| Dexus Convenience Retail REIT (DXC) FULLY PAID UNITS STAPLED SECURITIES |
Real Estate |
$379 |
Update - Notification of buy-back - DXC
|
28 Jan 2026 9:15AM |
$2.760 |
$2.750 |
fallen by
0.36%
|
|
Call 1300 880 160
Start a chat
Schedule a call
